Close Menu

At A Glance

Name: Richard Johnson

Age: 42

Position: Research Scientist 4, Amgen (until 2002: Immunex), since 1995

Prior Experience: PhD, MIT, 1983-88. Sequenced thioredoxins by tandem mass spectrometry in Klaus Biemann’s group.

Postdoc, Harvard School of Public Health, 1988-89

Postdoc, Biomembrane Institute, Seattle, 1990

Postdoc, University of Washington, Seattle, 1990-1995. Studied proteins and their posttranslational modifications by mass spectrometry with Ken Walsh.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Sponsored by

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.